The Department of Veterans Affairs is seeking qualified contractors to provide research laboratory services for DNA testing aimed at reducing veterans' risk of atherosclerotic cardiovascular disease through pharmacogenomics-informed statin prescribing. The project involves supporting the Health Science Research Department at the Durham VA Medical Center by conducting a randomized clinical trial with 410 veteran patients, comparing outcomes of genetic testing against standard care. This initiative is critical for enhancing clinical decision-making through advanced genetic testing services, including DNA sequencing and polygenic risk score calculations. Interested vendors must submit their capability statements by January 6, 2025, to Karly Gabrysiak at karly.gabrysiak@va.gov, as the anticipated contract duration is from January 13, 2025, to January 12, 2026, with options for yearly renewals.